UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer-Reference-Cited by-全球学者库

UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer

Published:2022-07 Issue:7 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Shoji Yoshiaki¹,Yokoe Takamichi¹,Kobayashi Yuta¹,Murakami Tomohiro¹,Bostick Peter J.²,Shiloh Yosef³,Hoon Dave S. B.¹^ORCID,Bustos Matias A.¹

Affiliation:

1. Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA

2. Mayo Clinic Care Network Baton Rouge General Medical Center Baton Rouge Louisiana USA

3. David and Inez Myers Laboratory for Cancer Genetics Tel Aviv University School of Medicine Tel Aviv Israel

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.985

Reference10 articles.

1. Breast cancer (version 7. 2021).National Comprehensive Cancer Network;2021. Accessed November 20 2021.https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

2. Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma

3. Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer;Cell & Bioscience;2023-11-06

2. Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles;International Journal of Molecular Sciences;2023-08-02

3. RIPK3–MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis;Clinical and Translational Medicine;2023-07

4. Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor;Cells;2022-10-21